Composition and method for treatment of MRSA
The present invention provides a photosensitizing composition for treatment of MRSA comprising a photosensitizer and chlorhexidine and a pharmaceutically acceptable carrier. The present invention also provides a method for reducing disease causing microbes comprising: applying the composition comprising a photosensitizer, chlorhexidine at a concentration of more than about 0.01% and less than about 2% v/v, and a pharmaceutically acceptable carrier to a treatment site; and applying light to the treatment site at a wavelength absorbed by the photosensitizer so as to reduce the microbes at the treatment site.
1. A method of treating Methicillin-resistant Staphylococcus aureus (“MRSA”) comprising:
(a) applying a photosensitizing composition to treatment site comprising: a phenothiazine at a concentration from about 0.001% wt to about 1% wt; chlorhexidine at a concentration from about 0.125% v/v to about 0.5% v/v; and a pharmaceutically acceptable carrier; and
(b) applying light to the treatment site at a wavelength absorbed by the photosensitizing composition so as to reduce the MRSA located at the treatment site.
2. The method of claim 1 wherein the phenothiazine is methylene blue.
3. The method of claim 1 wherein the phenothiazine is toluidine blue.
4. The method of claim 1 wherein chlorhexidine is chlorhexidine digluconate.
5. The method of claim 1 wherein concentration of the chlorhexidine is between about 0.25% v/v and about 0.5% v/v.
6. The composition of claim 1 wherein concentration of the phenothiazine is between about 0.01% wt to about 1% wt.
7. The method of claim 1 wherein the light applied to the treatment site in step (b) includes multiple wavelengths that are absorbed by the photosensitizing composition.
8. The method of claim 1 wherein the treatment site is the nasal cavity.
9. The method of claim 1 wherein the treatment site is anterior nasal nares.
10. A method for photodynamic disinfection of microbes comprising:
(a) applying a photosensitizing composition to treatment site comprising: a phenothiazine at a concentration from about 0.001% wt to about 1% wt; chlorhexidine at a concentration from about 0.125% v/v to about 0.5% v/v; and a pharmaceutically acceptable carrier; and
(b) applying light to the treatment site at a wavelength absorbed by the photosensitizing composition so as to reduce the microbes located at the treatment site.
11. The method of claim 10 wherein the phenothiazine is methylene blue.
12. The method of claim 10 wherein the phenothiazine is toluidine blue.
13. The method of claim 10 wherein chlorhexidine is chlorhexidine digluconate.
14. The method of claim 10 wherein concentration of the chlorhexidine is between about 0.25% v/v and about 0.5% v/v.
15. The method of claim 10 wherein concentration of the phenothiazine is between about 0.01% wt to about 0.1% wt.
16. The method of claim 10 wherein the light applied to the treatment site in step (b) includes multiple wavelengths that are absorbed by the photosensitizing composition.
17. The method of claim 10 wherein the treatment site is the nasal cavity.
18. The method of claim 10 wherein the microbes are selected from the group consisting of Methicillin-resistant Staphylococcus aureus, Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Aspergillus, Candida, Clostridium difficile, Staphylococcus epidermidis, Acinetobacter sp., Porphyromonas, Prevotella, Fusobacterium, Tannerella, Actinobacillus, Selenomonas, Eikenella, Campylobacter, Wolinella and a combination thereof.
19. A method for photodynamic disinfection of microbes comprising:
(a) applying a photosensitizing composition to treatment site comprising: an effective amount of phenothiazine; an effective amount of chlorhexidine; and a pharmaceutically acceptable carrier; and
(b) applying light to the treatment site at a wavelength absorbed by the photosensitizing composition so as to reduce the microbes located at the treatment; wherein the effective amount of phenothiazine and the effective amount of chlorhexidine produces a potentiation effect of antimicrobial efficacy during the photodynamic disinfection of microbes.
20. The method of claim 19 wherein the phenothiazine is methylene blue.
21. The method of claim 19 wherein the phenothiazine is toluidine blue.
22. The method of claim 19 wherein chlorhexidine is chlorhexidine digluconate.
23. The method of claim 19 wherein concentration of the chlorhexidine is between about 0.25% v/v and about 0.5% v/v.
24. The composition of claim 19 wherein concentration of the phenothiazine is between about 0.01% wt to about 1% wt.
25. The method of claim 19 wherein the light applied to the treatment site in step (b) includes multiple wavelengths that are absorbed by the photosensitizing composition.
26. The method of claim 19 wherein the microbes includes Methicillin resistant Staphylococcus aureus.
27. The method of claim 19 wherein the treatment site is the nasal cavity.
28. The method of claim 19 wherein the microbes are selected from the group consisting of Methicillin-resistant Staphylococcus aureus, Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Aspergillus, Candida, Clostridium difficile, Staphylococcus epidermidis, Acinetobacter sp., Porphyromonas, Prevotella, Fusobacterium, Tannerella, Actinobacillus, Selenomonas, Eikenella, Campylobacter, Wolinella and a combination thereof.